Ignite Creation Date:
2024-05-06 @ 7:43 PM
Last Modification Date:
2024-10-26 @ 3:12 PM
Study NCT ID:
NCT06115902
Status:
RECRUITING
Last Update Posted:
2023-11-29
First Post:
2023-10-30
Brief Title:
A Study of TQB2102 for Injection in Patients With RecurrentMetastatic Breast Cancer
Sponsor:
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co Ltd
Organization:
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-17
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-30
First Submit QC Date:
November 1 2023
Study First Post Date:
2023-11-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-24
Last Update Post Date:
2023-11-29
Last Update Post Date Type:
ACTUAL